Cancer Management and Research
Volume 11, 2019 - Issue
Open access
73
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
Josefine Redig1 ICON, Stockholm, Sweden
, Johan Dalén1 ICON, Stockholm, Sweden
, Ulrika Harmenberg2 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
, Magnus Lindskog3 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
, Börje Ljungberg4 Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden
, Sven Lundstam5 Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
, Rickard Sandin6 Pfizer AB, Sollentuna, Sweden, [email protected]
, Thomas Wahlgren6 Pfizer AB, Sollentuna, Sweden, [email protected]
, Örjan Åkerborg1 ICON, Stockholm, Sweden
& Maria Jakobsson6 Pfizer AB, Sollentuna, Sweden, [email protected]Correspondence[email protected]
show all
Pages 1289-1297
|
Published online: 08 Feb 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.